CLINICAL RESEARCH
STUDIES LOOKING FOR PATIENT VOLUNTEERS
Through research and treatment, we are aiming for an eventual cure for this disease.
Mitsubishi
We are looking for patients to test a new oral medication for sufficient skin involvement (diffuse systemic sclerosis) in a one-year placebo-controlled trial. Patients should have disease less than or equal to five years duration and should have active skin disease. Low-dose prednisone can be continued but other medications will need to be stopped. If you are possibly interested, please call.
Stanique Thomas
310-297-6812. or email at:
Stanique.pa.clinicalresearch@gmail.com.
There is a new trial available, testing an oral cannabinoid affecting two mechanisms for fibrosis. The trial is a 12-week rising dose trial versus placebo. Patients must have sufficient skin involvement(diffuse disease) and may have disease for up to six years. Most background medications and low-dose prednisone will be allowed. If you are possibly interested, please call Omar Aly at. 310-297-6812. or email at: Omar.pa.clinicalresearch@gmail.com
We are looking for patients for a 24-week trial of an intravenous medication (given every three weeks) versus placebo. There will be an additional 24-week follow-up. Patients must have sufficient skin involvement (modified Rodman skin score of 10 or more and diffuse disease) anddisease duration of up to five years. Background mycophenolate (CellCept/Myofortic) and low-dose prednisone are allowed but not required. If you are possibly interested, please call Stanique Thomas at. 310-297-6812. or email at: Stanique.pa.clinicalresearch@gmail.com
More To come
- Picori
- Prometheus
- Eustar
- Spin
- Bio Banking
- Male Fertility
- Kadmon




INFORMATION FOR SUBJECTS: RESEARCH STUDY
Principal Investigator:
Daniel E. Furst, MD
Pacific Arthritis Scleroderma Center
5230 Pacific Concourse Drive, Suite 100
Los Angeles, CA 90045-6200
Ph. 310-297-9221
Principal Investigator:
Suzanne Kafaja, MD
Westwood Specialty Care
200 Med Plaza, Ste. 365
Los Angeles, CA 90095
Ph. 310-825-2448